Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Trial details
- Registry ID
- NCT03519386
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Control Group
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%NCT03519386 | Glaukos Corporation | Phase 3 | Completed | 2022-04-05Actual |
| Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantNCT03868124 | Glaukos Corporation | Phase 3 | Completed | 2022-06-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |